Doctors have found that clopidogrel, a commonly prescribed blood thinner, is better than aspirin at preventing heart attacks and strokes, and with no extra risk | AI News Digest
A groundbreaking study has revealed that clopidogrel, a commonly prescribed blood thinner, is more effective than aspirin in preventing heart attacks and strokes, without increasing the risk of major bleeding. This finding, presented at the European Society of Cardiology congress and published in the Lancet, could lead to significant changes in health guidelines worldwide. The analysis included nearly 29,000 patients with coronary artery disease (CAD) and demonstrated a 14% lower risk of serious cardiovascular events for those taking clopidogrel. Experts suggest that clopidogrel should be preferred over aspirin for long-term treatment in CAD patients, potentially improving patient outcomes globally. The study's implications could reshape clinical practices and enhance the management of cardiovascular health.
